Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia

Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia

The aim of this review is to present data on bendamustine, a non-cross resistant alkylating agent, alone or in combination for treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Bendamustine is currently approved for rituximab-resistant indolent NHL and CLL in patients n...

Full description

Bibliographic Details
Main Authors: Martina Bogeljić Patekar, Vibor Milunović, Karla Mišura Jakobac, Dražen Perica, Inga Mandac Rogulj, Marin Kursar, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2018-01-01
Series:Acta Clinica Croatica
Subjects:
Bendamustine hydrochloride
Alkylating agents
Lymphoma, non-Hodgkin
Rituximab
Leukemia, lymphocytic, chronic, B-cell
Obinutuzumab
Online Access:https://hrcak.srce.hr/file/315443

Internet

https://hrcak.srce.hr/file/315443

Similar Items